EDGAR Filing Documents for 0001610618-19-000078

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001610618-19-000078

Filing Date

2019-11-08

Accepted

2019-11-07 21:13:46

Documents

Period of Report

2019-09-30

Document Format Files

Seq	Description	Document	Type	Size
1	CIDARA THERAPEUTICS, INC. FORM 10-Q	cdtx10-q2019x09.htm	10-Q	1285612
2	MUNDIPHARMA COLLABORATION AND LICENSE AGREEMENT	exhibit101.htm	EX-10.1	702066
3	MUNDIPHARMA STOCK PURCHASE AGREEMENT	exhibit102.htm	EX-10.2	149664
4	CERTIFICATION OF CEO PURSUANT TO SECURITIES EXCHANGE ACT OF 1934	exhibit311.htm	EX-31.1	9949
5	CERTIFICATION OF CFO PURSUANT TO SECURITIES EXCHANGE ACT OF 1934	exhibit312.htm	EX-31.2	9918
6	CERTIFICATION OF CEO PURSUANT TO SARBANES-OXLEY ACT OF 2002	exhibit321.htm	EX-32.1	7289
7	CERTIFICATION OF CFO PUSRUANT TO SARBANES-OXLEY ACT OF 2002	exhibit322.htm	EX-32.2	7411
14		cdtxlogo.jpg	GRAPHIC	63449
15		leadcompound.jpg	GRAPHIC	11437
16		mundipharmalogoa01.jpg	GRAPHIC	104326
	Complete submission text file	0001610618-19-000078.txt		6717656

Data Files

Seq	Description	Document	Type	Size
8	XBRL INSTANCE DOCUMENT	cdtx-20190930.xml	EX-101.INS	948852
9	XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT	cdtx-20190930.xsd	EX-101.SCH	45697
10	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT	cdtx-20190930_cal.xml	EX-101.CAL	65420
11	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT	cdtx-20190930_def.xml	EX-101.DEF	244363
12	XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT	cdtx-20190930_lab.xml	EX-101.LAB	604082
13	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT	cdtx-20190930_pre.xml	EX-101.PRE	359559

Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121

Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170

Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)